Green T, Dow J, Ellis M K, Foster J R, Odum J
Zeneca Central Toxicology Laboratory, Macclesfield, Cheshire, UK.
Chem Biol Interact. 1997 Jul 11;105(2):99-117. doi: 10.1016/s0009-2797(97)00040-9.
Trichloroethylene is metabolised to a very minor extent (< 0.01% of the dose) by conjugation with glutathione, a metabolic pathway which leads to the formation of S-(1,2-dichlorovinyl)-L-cysteine (DCVC), a bacterial mutagen and nephrotoxin activated by the renal enzyme beta-lyase. The role of this metabolic pathway in the development of the nephrotoxicity and subsequent tumour formation seen in rats exposed to trichloroethylene has been evaluated. The pathway has been assessed quantitatively in vivo in rats, and in rats, mice and humans in vitro. Trichloroethylene was found to be a very weak nephrotoxin. There was no evidence of morphological change in the kidneys and only small increases in biochemical markers of kidney damage in rats dosed with 2000 mg/kg trichloroethylene by gavage for 42 days. N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine was detected in the urine of rats dosed with 500 and 2000 mg/kg trichloroethylene for up to 10 days at levels equivalent to 0.001-0.008% of the dose. In vitro, the rate of conjugation of trichloroethylene with glutathione in the liver was higher in the mouse, 2.5 pmol/min per mg protein, than the rat, 1.6 pmol/min per mg protein, and in human liver the rates were extremely low, 0.02-0.37 pmol/min per mg protein. Comparisons of the metabolism of DCVC by renal beta-lyase and N-acetyl transferase showed that metabolism by N-acetyl transferase was two orders of magnitude greater than that by beta-lyase and that beta-lyase activity in rat kidney was 11-fold greater than that in human kidney. When the nephrotoxicity of DCVC was compared in rats and mice, the mouse was found to be 5-10 fold more sensitive than the rat. The no effect level in the rat was 10 mg/kg, a dose which is three orders of magnitude higher than the amount of DCVC formed from trichloroethylene in vivo. The lack of correlation between metabolism by this pathway and the rat specific tumours, together with questions concerning the potency of DCVC at the levels formed from trichloroethylene, suggests that DCVC may not be involved in the renal toxicity and subsequent tumour development seen in rats and that further evaluation of the mechanism(s) involved in the nephrotoxic response is warranted.
三氯乙烯与谷胱甘肽结合的代谢程度非常低(占剂量的<0.01%),该代谢途径会导致形成S-(1,2-二氯乙烯基)-L-半胱氨酸(DCVC),这是一种细菌诱变剂和肾毒素,可被肾酶β-裂解酶激活。已评估了该代谢途径在接触三氯乙烯的大鼠中肾毒性和后续肿瘤形成过程中的作用。该途径已在大鼠体内以及大鼠、小鼠和人类的体外进行了定量评估。发现三氯乙烯是一种非常弱的肾毒素。给大鼠经口灌胃2000 mg/kg三氯乙烯,持续42天,未发现肾脏有形态学变化的证据,肾脏损伤的生化标志物仅有小幅升高。在给大鼠分别灌胃500 mg/kg和2000 mg/kg三氯乙烯长达10天的尿液中检测到了N-乙酰-S-(1,2-二氯乙烯基)-L-半胱氨酸,其含量相当于剂量的0.001 - 0.008%。在体外,小鼠肝脏中三氯乙烯与谷胱甘肽的结合速率为2.5 pmol/分钟每毫克蛋白质,高于大鼠的1.6 pmol/分钟每毫克蛋白质,而在人肝脏中该速率极低,为0.02 - 0.37 pmol/分钟每毫克蛋白质。对肾β-裂解酶和N-乙酰转移酶对DCVC的代谢比较表明,N-乙酰转移酶的代谢比β-裂解酶大两个数量级,且大鼠肾脏中的β-裂解酶活性比人肾脏高11倍。当比较DCVC在大鼠和小鼠中的肾毒性时,发现小鼠比大鼠敏感5 - 10倍。大鼠的无效应水平为10 mg/kg,该剂量比三氯乙烯在体内形成的DCVC量高三个数量级。该途径的代谢与大鼠特定肿瘤之间缺乏相关性,以及关于三氯乙烯形成的DCVC水平下其效力的问题,表明DCVC可能与大鼠中观察到的肾毒性和后续肿瘤发展无关,有必要进一步评估涉及肾毒性反应的机制。